國家衛生研究院 NHRI:Item 3990099045/11049
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 912450      Online Users : 1197
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11049


    Title: Role of academic institute in cancer therapy development in National Institute of Cancer Research, NHRI in Taiwan
    Authors: Chen, LT
    Contributors: National Institute of Cancer Research
    Abstract: National Health Research Institutes (NHRI) is a non-profit organization established by the Taiwan government in 1996. Among the 10 research units, 8 research institutes and two research centers, the National Institute of Cancer Research (NICR) and the Institute of Biotechnology and Pharmaceutical Research (IBPR) are involved in cancer therapy development. NICR aims to ascertain statistically efficacious new drugs and therapy for locally prevalent cancers through clinical trials. Whiles, IBPR is a fully integrated institute with multi-disciplinary technologies cover major aspects of the drug discovery and development. Such an integrated infrastructure facilitates the new drug development within NHRI. For instance, NICR joined in the pre-clinical and clinical development of a vascular-disrupting, anti-microtubular agent, DPRB104.Besides the intramural collaboration, NICR also plays an important role in helping the new drug development for domestic pharmaceutical companies. Regarding investigator-initiated trials, NICR explored the commercial available, off-labeled agents as well as yet approval agents for treating domestic prevalent cancers.
    Date: 2018-01
    Relation: Cancer Science. 2018 Jan;109(Suppl. 1):43.
    Link to: http://dx.doi.org/10.1111/cas.13499
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000422694001077
    Appears in Collections:[Li-Tzong Chen] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI000422694001077.pdf44KbAdobe PDF146View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback